There is one clinical trial.
The purpose of this randomized controlled trial is to evaluate a fully automated algorithm for the establishment of glycemic control in diabetic patients and to compare the results with routine management of hyperglycemia in patients undergoing cardiopulmonary bypass surgery.
The same intervention will be repeated in case this level wasn't reached and patient will be withdrawn from the study after two failed correction and will be treated more aggressively with an infusion of D10W. --- D10W ---
Description: The reduction of this percentage to less than 10% with the fully automated algorithm as clinically significantMeasure: Percentage of patients who will have a serum glucose level between 140-180mg/dl during surgery. Time: Approximately 1 year